MODV250516C7500
- 0.05
- 0.000.00%
ModivCare Newsroom
ModivCare Is Maintained at Equal-Weight by Stephens & Co.
Stephens Maintains ModivCare(MODV.US) With Hold Rating, Announces Target Price $3.5
ModivCare Is Maintained at Outperform by Barrington Research
ModivCare Analyst Ratings
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Cuts Target Price to $6
ModivCare Is Maintained at Outperform by Barrington Research
ModivCare Price Target Cut to $10.00/Share From $25.00 by Barrington Research
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Cuts Target Price to $10
ModivCare's Strategic Initiatives and Financial Outlook Justify Buy Rating Despite Speculative Risks
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Cuts Target Price to $10
ModivCare Cut to Equal-Weight From Overweight by Stephens & Co.
ModivCare Analyst Ratings
Stephens Downgrades ModivCare(MODV.US) to Hold Rating, Cuts Target Price to $17
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $25
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $25
ModivCare's Growth Potential and Asset Value Highlighted Amid Financial Restructuring: Buy Rating With $25 Price Target
ModivCare Is Maintained at Outperform by Barrington Research
ModivCare Analyst Ratings
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Raises Target Price to $25
Deutsche Bank Maintains ModivCare(MODV.US) With Hold Rating, Cuts Target Price to $18